541 related articles for article (PubMed ID: 27046891)
1. A Novel Grading Biomarker for the Prediction of Conversion From Mild Cognitive Impairment to Alzheimer's Disease.
Tong T; Gao Q; Guerrero R; Ledig C; Chen L; Rueckert D; Initiative ADN
IEEE Trans Biomed Eng; 2017 Jan; 64(1):155-165. PubMed ID: 27046891
[TBL] [Abstract][Full Text] [Related]
2. Machine learning framework for early MRI-based Alzheimer's conversion prediction in MCI subjects.
Moradi E; Pepe A; Gaser C; Huttunen H; Tohka J;
Neuroimage; 2015 Jan; 104():398-412. PubMed ID: 25312773
[TBL] [Abstract][Full Text] [Related]
3. Performance of Hippocampus Volumetry with FSL-FIRST for Prediction of Alzheimer's Disease Dementia in at Risk Subjects with Amnestic Mild Cognitive Impairment.
Suppa P; Hampel H; Kepp T; Lange C; Spies L; Fiebach JB; Dubois B; Buchert R;
J Alzheimers Dis; 2016; 51(3):867-73. PubMed ID: 26923010
[TBL] [Abstract][Full Text] [Related]
4. Multi-modality sparse representation-based classification for Alzheimer's disease and mild cognitive impairment.
Xu L; Wu X; Chen K; Yao L
Comput Methods Programs Biomed; 2015 Nov; 122(2):182-90. PubMed ID: 26298855
[TBL] [Abstract][Full Text] [Related]
5. Discerning mild cognitive impairment and Alzheimer Disease from normal aging: morphologic characterization based on univariate and multivariate models.
Liao W; Long X; Jiang C; Diao Y; Liu X; Zheng H; Zhang L;
Acad Radiol; 2014 May; 21(5):597-604. PubMed ID: 24433704
[TBL] [Abstract][Full Text] [Related]
6. Multi-stage Biomarker Models for Progression Estimation in Alzheimer's Disease.
Schmidt-Richberg A; Guerrero R; Ledig C; Molina-Abril H; Frangi AF; Rueckert D;
Inf Process Med Imaging; 2015; 24():387-98. PubMed ID: 26221689
[TBL] [Abstract][Full Text] [Related]
7. Biomarker Extraction Based on Subspace Learning for the Prediction of Mild Cognitive Impairment Conversion.
Li Y; Fang Y; Wang J; Zhang H; Hu B
Biomed Res Int; 2021; 2021():5531940. PubMed ID: 34513992
[TBL] [Abstract][Full Text] [Related]
8. Effects of imaging modalities, brain atlases and feature selection on prediction of Alzheimer's disease.
Ota K; Oishi N; Ito K; Fukuyama H; ;
J Neurosci Methods; 2015 Dec; 256():168-83. PubMed ID: 26318777
[TBL] [Abstract][Full Text] [Related]
9. Multimodal manifold-regularized transfer learning for MCI conversion prediction.
Cheng B; Liu M; Suk HI; Shen D; Zhang D;
Brain Imaging Behav; 2015 Dec; 9(4):913-26. PubMed ID: 25702248
[TBL] [Abstract][Full Text] [Related]
10. Prediction of Incipient Alzheimer's Disease Dementia in Patients with Mild Cognitive Impairment.
Ardekani BA; Bermudez E; Mubeen AM; Bachman AH;
J Alzheimers Dis; 2017; 55(1):269-281. PubMed ID: 27662309
[TBL] [Abstract][Full Text] [Related]
11. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
Löwe LC; Gaser C; Franke K;
PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
[TBL] [Abstract][Full Text] [Related]
12. Defining multivariate normative rules for healthy aging using neuroimaging and machine learning: an application to Alzheimer's disease.
Andrade de Oliveira A; Carthery-Goulart MT; Oliveira Júnior PP; Carrettiero DC; Sato JR
J Alzheimers Dis; 2015; 43(1):201-12. PubMed ID: 25079801
[TBL] [Abstract][Full Text] [Related]
13. Accurate Prediction of Conversion to Alzheimer's Disease using Imaging, Genetic, and Neuropsychological Biomarkers.
Dukart J; Sambataro F; Bertolino A
J Alzheimers Dis; 2016; 49(4):1143-59. PubMed ID: 26599054
[TBL] [Abstract][Full Text] [Related]
14. Optimization of Statistical Single Subject Analysis of Brain FDG PET for the Prognosis of Mild Cognitive Impairment-to-Alzheimer's Disease Conversion.
Lange C; Suppa P; Frings L; Brenner W; Spies L; Buchert R
J Alzheimers Dis; 2016; 49(4):945-959. PubMed ID: 26577523
[TBL] [Abstract][Full Text] [Related]
15. Modelling prognostic trajectories of cognitive decline due to Alzheimer's disease.
Giorgio J; Landau SM; Jagust WJ; Tino P; Kourtzi Z;
Neuroimage Clin; 2020; 26():102199. PubMed ID: 32106025
[TBL] [Abstract][Full Text] [Related]
16. Local MRI analysis approach in the diagnosis of early and prodromal Alzheimer's disease.
Chincarini A; Bosco P; Calvini P; Gemme G; Esposito M; Olivieri C; Rei L; Squarcia S; Rodriguez G; Bellotti R; Cerello P; De Mitri I; Retico A; Nobili F;
Neuroimage; 2011 Sep; 58(2):469-80. PubMed ID: 21718788
[TBL] [Abstract][Full Text] [Related]
17. Locally linear embedding (LLE) for MRI based Alzheimer's disease classification.
Liu X; Tosun D; Weiner MW; Schuff N;
Neuroimage; 2013 Dec; 83():148-57. PubMed ID: 23792982
[TBL] [Abstract][Full Text] [Related]
18. An evaluation of volume-based morphometry for prediction of mild cognitive impairment and Alzheimer's disease.
Schmitter D; Roche A; Maréchal B; Ribes D; Abdulkadir A; Bach-Cuadra M; Daducci A; Granziera C; Klöppel S; Maeder P; Meuli R; Krueger G;
Neuroimage Clin; 2015; 7():7-17. PubMed ID: 25429357
[TBL] [Abstract][Full Text] [Related]
19. Sparse learning and stability selection for predicting MCI to AD conversion using baseline ADNI data.
Ye J; Farnum M; Yang E; Verbeeck R; Lobanov V; Raghavan N; Novak G; DiBernardo A; Narayan VA;
BMC Neurol; 2012 Jun; 12():46. PubMed ID: 22731740
[TBL] [Abstract][Full Text] [Related]
20. Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: results from ADNI.
Misra C; Fan Y; Davatzikos C
Neuroimage; 2009 Feb; 44(4):1415-22. PubMed ID: 19027862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
